Institutional Biosafety Committee

Florida Atlantic is committed to compliance with Federal, State and Local guidelines and regulations as they apply to research. Federal Guidelines mandate that any entity receiving federal funding and conducting research with recombinant/synthetic nucleic acid molecules must have an Institutional Biosafety Committee (IBC) to review such activities. The Florida Atlantic IBC has been delegated the authority to set University policy with regard to research with recombinant/synthetic nucleic acid molecules and biological materials, agents and toxins. The Florida Atlantic IBC functions include those designated for the IBC in the National Institutes of Health (NIH) Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules, and, consistent with other universities across the country, the control of health hazards associated with the use of biological materials, agents and toxins.

If your project involves the handling of any of the following:

• Recombinant or synthetic nucleic acid molecules
• Microorganisms (including those found on animals handled in the field)
• Biologically derived toxins or venoms
• Human or nonhuman primate biological materials (including cell lines, saliva, blood, or tissue)
• Dual Use Research of Concern (https://osp.od.nih.gov/biotechnology/dual-use-research-of-concern/)

Florida Atlantic policy requires IBC registration.